BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24094964)

  • 1. Down-regulation of MeCP2 in Hirschsprung's disease.
    Zhou Z; Qin J; Tang J; Li B; Geng Q; Jiang W; Wu W; Rehan V; Tang W; Xu X; Xia Y
    J Pediatr Surg; 2013 Oct; 48(10):2099-105. PubMed ID: 24094964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant reduction of MiR-141 increased CD47/CUL3 in Hirschsprung's disease.
    Tang W; Qin J; Tang J; Zhang H; Zhou Z; Li B; Geng Q; Wu W; Xia Y; Xu X
    Cell Physiol Biochem; 2013; 32(6):1655-67. PubMed ID: 24334875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of down-regulated E2F3 in Hirschsprung's disease.
    Tang W; Tang J; Qin J; Geng Q; Zhou Z; Li B; Zhang J; Chen H; Xia Y; Wang X
    J Pediatr Surg; 2013 Apr; 48(4):813-7. PubMed ID: 23583139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of MiR-369-3p suppresses cell migration and proliferation by targeting SOX4 in Hirschsprung's disease.
    Pan W; Yu H; Zheng B; Gao Y; Li P; Huang Q; Xie C; Ge X
    J Pediatr Surg; 2017 Aug; 52(8):1363-1370. PubMed ID: 28412032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-195 affects cell migration and cell proliferation by down-regulating DIEXF in Hirschsprung's disease.
    Lei H; Tang J; Li H; Zhang H; Lu C; Chen H; Li W; Xia Y; Tang W
    BMC Gastroenterol; 2014 Jul; 14():123. PubMed ID: 25007945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased MiR-200a/141 suppress cell migration and proliferation by targeting PTEN in Hirschsprung's disease.
    Li H; Tang J; Lei H; Cai P; Zhu H; Li B; Xu X; Xia Y; Tang W
    Cell Physiol Biochem; 2014; 34(2):543-53. PubMed ID: 25116353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-140-5p affects the pathogenesis of HSCR by targeting EGR2.
    Du G; Wang X; Wu Y; Zhang Y; Liu W; Wu R
    Pediatr Surg Int; 2020 Aug; 36(8):883-890. PubMed ID: 32507977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nidogen-1 is a common target of microRNAs MiR-192/215 in the pathogenesis of Hirschsprung's disease.
    Zhu D; Xie H; Li H; Cai P; Zhu H; Xu C; Chen P; Sharan A; Xia Y; Tang W
    J Neurochem; 2015 Jul; 134(1):39-46. PubMed ID: 25857602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of dishevelled gene in Hirschsprung's disease.
    Chen D; Mi J; Wu M; Wang W; Gao H
    Int J Clin Exp Pathol; 2013; 6(9):1791-8. PubMed ID: 24040443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLIT2/ROBO1-miR-218-1-RET/PLAG1: a new disease pathway involved in Hirschsprung's disease.
    Tang W; Tang J; He J; Zhou Z; Qin Y; Qin J; Li B; Xu X; Geng Q; Jiang W; Wu W; Wang X; Xia Y
    J Cell Mol Med; 2015 Jun; 19(6):1197-207. PubMed ID: 25786906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MiR-215 in Hirschsprung's Disease Pathogenesis by Targeting SIGLEC-8.
    Lei H; Li H; Xie H; Du C; Xia Y; Tang W
    Cell Physiol Biochem; 2016; 40(6):1646-1655. PubMed ID: 28006787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of IL36γ and IL36 receptor (IL1RL2) in the colon of patients with Hirschsprung's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Puri P
    Pediatr Surg Int; 2017 Feb; 33(2):181-186. PubMed ID: 27853811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of LINC00346 regulates cell migration and proliferation via competitively binding to miRNA-148a-3p/Dnmt1 in Hirschsprung's disease.
    Li L; Li X; Wang X; Liu W; Wu R
    Pediatr Surg Int; 2022 Sep; 38(9):1273-1281. PubMed ID: 35836014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOS-interacting protein (NOSIP) is increased in the colon of patients with Hirschsprungs's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Dreher N; Kelly D; Puri P
    J Pediatr Surg; 2017 May; 52(5):772-777. PubMed ID: 28196663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-483-5p Promotes Cell Proliferation and Invasion by Targeting GFRA4 in Hirschsprung's Disease.
    Wang G; Guo F; Wang H; Liu W; Zhang L; Cui M; Wu X
    DNA Cell Biol; 2017 Nov; 36(11):930-937. PubMed ID: 29090971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Scn1b and Fxyd1 gene expression in the pulled-through ganglionic colon may influence functional outcome in patients with Hirschsprung's disease.
    O'Donnell AM; Nakamura H; Tomuschat C; Marayati NF; Puri P
    Pediatr Surg Int; 2019 Jan; 35(1):9-14. PubMed ID: 30386899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of KCNG3 and KCNG4 in Hirschsprung's disease.
    O'Donnell AM; Nakamura H; Tomuschat C; Marayati NF; Puri P
    Pediatr Surg Int; 2019 Feb; 35(2):193-197. PubMed ID: 30386900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered goblet cell function in Hirschsprung's disease.
    Nakamura H; Tomuschat C; Coyle D; O'Donnel AM; Lim T; Puri P
    Pediatr Surg Int; 2018 Feb; 34(2):121-128. PubMed ID: 29383490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered neurotransmitter expression profile in the ganglionic bowel in Hirschsprung's disease.
    Coyle D; O'Donnell AM; Gillick J; Puri P
    J Pediatr Surg; 2016 May; 51(5):762-9. PubMed ID: 26951962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-144 blocked the proliferation and invasion of nerve cells in Hirschsprung disease by regulating Transcription Factor AP 4 (TFAP4).
    Zheng H; Wu D; Chen H; Bai J; Fang Y
    Pediatr Surg Int; 2023 Aug; 39(1):251. PubMed ID: 37610449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.